Navigation Links
Angiotech wins before the UK House of Lords
Date:7/10/2008

me time frame several courts in the Netherlands, following the approach of the EPO and concluded that Angiotech's claimed invention was inventive and not obvious in view of the same publications. Angiotech appealed the UK lower court decisions to the House of Lords seeking to resolve these inconsistent outcomes.

In his lead opinion upholding the validity of Angiotech's patent, Lord Hoffmann did not agree with the reasoning that the UK lower courts used in justifying revocation and instead agreed with the opinion of the Dutch Court. The House of Lords' unanimous decision reflects an important development in bringing uniformity to the interpretation of the European Patent Convention among the national courts of Europe and the European Patent Office.

Note on Forward Looking Statements:

Statements contained in this press release that are not based on historical fact, including without limitation statements containing the words "believes," "may," "plans," "will," "estimate," "continue," "anticipates," "intends," "expects" and similar expressions, constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and constitute "forward-looking information" within the meaning of applicable Canadian securities laws. All such statements are made pursuant to the "safe harbor" provisions of applicable securities legislation. Forward-looking statements may involve, but are not limited to, comments with respect to our objectives and priorities for 2007 and beyond, our strategies or future actions, our targets, expectations for our financial condition and the results of, or outlook for, our operations, research development and product and drug development. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from any future results, events or developments expressed or implied by
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 BCC Research ( http://www.bccresearch.com ) ... Enzymes in Industrial Applications , the global market for ... billion by 2018, registering a five-year compound annual growth ... be recorded in the detergent enzyme segment with a ... technology has influenced almost every sector of industrial activity, ...
(Date:7/30/2014)... July 30, 2014  Dyadic International, Inc. ("Dyadic") ... patented and proprietary technologies are used to discover, ... for the bioenergy, bio-based chemical, biopharmaceutical and industrial ... "Tom" Dubinski as Vice President and Chief Financial ... financial and information technology operations for Dyadic and ...
(Date:7/30/2014)... July 30, 2014  RXi Pharmaceuticals Corporation ... company focused on discovering, developing and commercializing ... using RNA-targeted technologies, today announced that their ... for the reduction of recurrence of hypertrophic ... been initiated. Logo - ...
(Date:7/30/2014)... 2014 Adding to their already extensive ... special – Buy 2 of any Weighing Boats ... benefit lab technicians looking for durable and reliable weighing ... for multiple applications including weighing liquids, solid, or granulated ... including diamond-shaped, hexagonal, square, aluminum weighing, and standard boats. ...
Breaking Biology Technology:Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 2Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 3Thomas Dubinski joins Dyadic as Chief Financial Officer 2Thomas Dubinski joins Dyadic as Chief Financial Officer 3Thomas Dubinski joins Dyadic as Chief Financial Officer 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 2RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 3RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 5Weighing Boat Promotion Now Available at Pipette.com, Major Pipette Distributor 2
... (OTC.BB: FPMI), a biopharmaceutical company developing the ... of its official stock ticker symbol from CEWM to ... previously announced FluoroPharma Inc. merger with CEWM. ... biopharmaceutical company engaged in the discovery and development of ...
... N.C., June 3, 2011 Recent biopharmaceutical product launches ... the cardiovascular therapeutic area. Faced with a continually evolving ... the biggest role in the current launch environment. ... explores the pivotal success factors and failure points facing ...
... 3, 2011 LifeVantage Corporation (OTCBB: ... science-based therapy for the reduction of oxidative stress ... that a new peer-reviewed review article involving Protandim® ... Research .   (Logo:   http://photos.prnewswire.com/prnh/20090930/LIFEVANTAGELOGO ...
Cached Biology Technology:FluoroPharma Medical Announces Stock Ticker Symbol Change 2Creating a Road Map for Successful Cardiovascular New Product Launch 2LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 2LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 3LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 4LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 5
(Date:7/29/2014)... world of science, researchers sometimes need to get ... did just that to study the impacts of ... coral reef ecosystems at two remote locations in ... animal tracking and computer simulation, McCauley, an assistant ... Marine Biology, and his colleagues sought to understand ...
(Date:7/29/2014)... plays a major role in locomotion. Swimming microorganisms, such ... inertial forces compared to the viscous forces exerted by ... a major challenge. Now, scientists have found that the ... opposite to that induced by a viscoelastic fluid. These ... by Franois Nadal from the Alternative Energies and Atomic ...
(Date:7/29/2014)... on the remote UK overseas territory of Ascension Island, ... undergoing something of a renaissance. , Writing in the ... University of Exeter and Ascension Island Government Conservation Department ... the remote South Atlantic outpost has increased by more ... 1970s. As many as 24,000 nests are now estimated ...
Breaking Biology News(10 mins):Underwater elephants 2Underwater elephants 3Optimum inertial self-propulsion design for snowman-like nanorobot 2Major turtle nesting beaches protected in 1 of the UK's far flung overseas territories 2
... Efforts on the Growing Issue of Identity Management , ... WASHINGTON , July ... today announced that it has expanded its mission to focus on the ... biometric and other technologies play an increasingly important role, has been deemed ...
... Having discovered a dramatic increase of an easy-to-detect enzyme ... prediabetes, Johns Hopkins scientists say the discovery could lead to ... the disease, before symptoms or complications occur and in time ... 22 in Diabetes , show the enzyme O-GlcNAcase is ...
... 8, 2010 A new system for the controlled ... team of University of Rhode Island chemical engineers using ... by non-invasive electromagnetic fields. The discovery by URI ... Yanjing Chen was published in the June issue of ...
Cached Biology News:The International Biometrics & Identification Association (IBIA) Sets New Course to Benefit Consumers, Businesses and Governments Across the Globe 2The International Biometrics & Identification Association (IBIA) Sets New Course to Benefit Consumers, Businesses and Governments Across the Globe 3Hopkins team discovers sweet way to detect prediabetes 2Researchers develop drug delivery system using nanoparticles triggered by electromagnetic field 2
MMP-20 Immunogen: Activated recombinant human MMP-2 Storage: -20 C, Avoid Freeze/Thaw Cycles...
Rabbit anti-T-box 6...
Anti-Rsk2/MAPKAP Kinase 1b, #0 SK2/MAPKAP K1 beta Smartpool&t 3T3 cell lysate Non-specific Control Pool , #D 1X Universal Buffer...
...
Biology Products: